Carmona Jose 4
4 · Rubius Therapeutics, Inc. · Filed Feb 1, 2022
Insider Transaction Report
Form 4
Carmona Jose
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-01-31+143,750→ 143,750 totalExercise: $6.75Exp: 2032-01-30→ Common Stock (143,750 underlying) - Award
Restricted Stock Units
2022-01-31+34,500→ 34,500 total→ Common Stock (34,500 underlying)
Footnotes (3)
- [F1]25% of this option shall vest on January 31, 2023, then in 12 equal quarterly installments thereafter.
- [F2]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- [F3]The shares underlying the restricted stock units vest in four equal annual installments beginning on January 31, 2023.